Publications

1. Matilla JM, García Yuste M,  Sanchez Crespo M,  Gayoso MJ, Heras  F, Jiménez Prada M, Alonso  A,  Ramos G. Interleukin-8 expression in lung tissue during ischemia-reperfusion. Arch Bronconeumol 2007; 43:542-548.
2. García-Yuste M,  Molins  L,  Matilla JM,  González-Aragoneses F,  López-Pujol J, Ramos G,  de la Torre M, y Miembros del Estudio Multicéntrico Español de los Tumores Neuroendocrinos del Pulmón de la Sociedad Española de Neumología y Cirugía Torácica (EMETNE-SEPAR). Trends in prognostic factors for neuroendocrine lung tumors Arch Bronconeumol  2007; 43:549-556.
3. García-Yuste M,  Matilla  JM,  Cueto A,  Rodríguez Paniagua JM,  Ramos G,  Cañizares  MA,  Muguruza I and Members of the Spanish Multicenter Study of Neuroendocrine Tumors of the Lung by the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).  Typical and atypical carcinoid: analysis of the experience of the Spanish multicenter study of neuroendocrine tumors of the lung Eur J Cardiothorac Surg 2007; 31: 192-197.
4. González Aragoneses F,  Moreno Mata N, Cebollero Presmanes M,  García Yuste M,  Cañizares Carretero MA,  Molins López-Rodó L,   Quevedo Losada S,  Torres Lanzas J,  Álvarez Fernández E, and the Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). Prognosis Signficance of Synaptosin in Stage I of No Small Cells Lung Carcinoma. Cancer 2007;110: 1776-81.
5. García-Yuste M, Matilla JM,Gonzalez-Aragoneses F. Neuroendocrine lung tumors. Current Opinion Oncology 2008, 20:148–154.
6. García-Yuste M, Cassivi S, Paleru C. The number of pulmonary metastases: influence on practice and outcome. J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S161-3.
7. García-Yuste M, Cassivi S, Paleru C.  Thoracic lymphatic involvement in patients having pulmonary metastasectomy: incidence and the effect on prognosis. J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S166-9
   
8. García-Yuste M, Cassivi S, Paleru C. Pulmonary metastasectomy in  reast cancer. J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S170-1.
   
9. García-Yuste M, MatillaJM, González Aragoneses F, Heras F.Detection of lymph node involvement and surgical treatment of pulmonary neoplastic processes. Current state of diagnostic and therapeutic procedures.Arch Bronconeumol. 2010 Mar;46 Suppl 1:43-9.
10. Lara B, Morales P, Blanco I, Vendrell M, de Gracia Roldán J, Monreal M, Orriols R, Isidro I, Abú-Shams K, Escribano P, Villena V, Rodrigo T, Vidal Plà R, García-Yuste M, Miravitlles M. Respiratory disease registries in Spain: fundamentals and organization. Arch Bronconeumol.2011;47:389-96.
11. Muguruza I,. Aranda JL,  García-Yuste M.Treatment of lung cancer with chest wall invasión Arch Bronconeumol.2011; 47 Supl.1:27-32.
12. Cañizares MA1, Matilla JM2, Cueto A3, Algar J4, Muguruza I5, Moreno-Mata N6, Moreno-Balsalobre R7, Guijarro R8, Arrabal R9, Garcia-Fontan E1, Gonzalez-Piñeiro A1, Garcia-Yuste M2; EMETNE-SEPAR Members Atypical carcinoid tumours of the lung: prognostic factors and patterns of recurrence. Thorax. 2014 Jul;69(7):648-53. doi: 10.1136/thoraxjnl-2013-204102. Epub 2014 Mar 6.
13. García-Yuste M, Matilla JM. The significance of histology: typical and atypical bronchial carcinoids.Thorac Surg Clin. 2014 Aug;24(3):293-7. doi:  10.1016/j.thorsurg.2014.05.003.
14. Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD; the ENETS consensus conference participants. Pulmonary Neuroendocrine (Carcinoid) Tumors: European Neuroendocrine Tumor Society Expert Consensus and  Recommendations for Best Practice for Typical and Atypical Pulmonary Carcinoid. Ann Oncol. 2015 Feb 2. pii: mdv041. [Epub ahead of print]